The store will not work correctly when cookies are disabled.
3-(2-benzoyloxy)ethoxy-2,6-difluorobenzamide
ID: ALA4089694
PubChem CID: 137643045
Max Phase: Preclinical
Molecular Formula: C16H13F2NO3
Molecular Weight: 305.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCCC(=O)c2ccccc2)c1F
Standard InChI: InChI=1S/C16H13F2NO3/c17-11-6-7-13(15(18)14(11)16(19)21)22-9-8-12(20)10-4-2-1-3-5-10/h1-7H,8-9H2,(H2,19,21)
Standard InChI Key: VEBWOFAQZNIFMR-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
15.8967 -10.2396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8955 -11.0592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6036 -11.4681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3132 -11.0587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3104 -10.2360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6018 -9.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0166 -9.8248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7258 -10.2307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0135 -9.0076 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4320 -9.8194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1412 -10.2254 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8474 -9.8141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5526 -10.2218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2583 -9.8112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2557 -8.9931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5415 -8.5874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8387 -9.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1273 -8.5982 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.5355 -7.7702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2402 -7.3565 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8248 -7.3668 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9613 -8.5809 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
17 18 1 0
16 19 1 0
19 20 1 0
19 21 2 0
15 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 305.28 | Molecular Weight (Monoisotopic): 305.0863 | AlogP: 2.72 | #Rotatable Bonds: 6 |
Polar Surface Area: 69.39 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: ┄ | CX LogP: 2.42 | CX LogD: 2.42 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.83 | Np Likeness Score: -1.06 |
References
1. Hu Z, Zhang S, Zhou W, Ma X, Xiang G.. (2017) Synthesis and antibacterial activity of 3-benzylamide derivatives as FtsZ inhibitors., 27 (8): [PMID:28285910] [10.1016/j.bmcl.2017.02.032] |